应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CNSP CNS Pharmaceuticals, Inc.
盘前交易 11-22 06:22:15 EST
0.1300
+0.0064
+5.18%
盘前
0.1250
-0.0050
-3.85%
05:14 EST
最高
0.1450
最低
0.1270
成交量
3,364万
今开
0.1320
昨收
0.1236
日振幅
14.56%
总市值
747.33万
流通市值
732.90万
总股本
5,749万
成交额
450.50万
换手率
59.66%
流通股本
5,638万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Cns Pharmaceuticals, Inc.盘中异动 股价大涨12.70%报0.139美元
市场透视 · 11-21 22:32
Cns Pharmaceuticals, Inc.盘中异动 股价大涨12.70%报0.139美元
Cns Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.21%报0.133美元
市场透视 · 11-21 00:49
Cns Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.21%报0.133美元
Cns Pharmaceuticals, Inc.盘中异动 早盘快速下挫5.17%
市场透视 · 11-19 23:08
Cns Pharmaceuticals, Inc.盘中异动 早盘快速下挫5.17%
Cns Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.52%
市场透视 · 11-18
Cns Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.52%
Cns Pharmaceuticals, Inc.盘中异动 大幅下跌5.30%报0.113美元
市场透视 · 11-15
Cns Pharmaceuticals, Inc.盘中异动 大幅下跌5.30%报0.113美元
Cns Pharmaceuticals, Inc.盘中异动 股价大跌5.46%报0.118美元
市场透视 · 11-14
Cns Pharmaceuticals, Inc.盘中异动 股价大跌5.46%报0.118美元
CNS Pharmaceuticals Inc 预计每股亏损 10 美分 - 财报前瞻
Reuters · 11-11
CNS Pharmaceuticals Inc 预计每股亏损 10 美分 - 财报前瞻
Cns Pharmaceuticals, Inc.盘中异动 股价大涨5.22%报0.123美元
市场透视 · 11-11
Cns Pharmaceuticals, Inc.盘中异动 股价大涨5.22%报0.123美元
Cns Pharmaceuticals, Inc.盘中异动 急速上涨5.42%报0.117美元
市场透视 · 11-06
Cns Pharmaceuticals, Inc.盘中异动 急速上涨5.42%报0.117美元
Cns Pharmaceuticals, Inc.盘中异动 股价大涨5.51%报0.113美元
市场透视 · 11-05
Cns Pharmaceuticals, Inc.盘中异动 股价大涨5.51%报0.113美元
Cns Pharmaceuticals, Inc.股价重挫10.21% 市值跌42.05万美元
市场透视 · 11-04
Cns Pharmaceuticals, Inc.股价重挫10.21% 市值跌42.05万美元
Cns Pharmaceuticals, Inc.盘中异动 早盘股价大涨15.05%
市场透视 · 11-01
Cns Pharmaceuticals, Inc.盘中异动 早盘股价大涨15.05%
Cns Pharmaceuticals, Inc.盘中异动 快速下挫5.35%报0.115美元
市场透视 · 10-31
Cns Pharmaceuticals, Inc.盘中异动 快速下挫5.35%报0.115美元
Cns Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.52%
市场透视 · 10-30
Cns Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.52%
Cns Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.22%报0.139美元
市场透视 · 10-28
Cns Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.22%报0.139美元
Cns Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.22%报0.138美元
市场透视 · 10-25
Cns Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.22%报0.138美元
阿里拉姆制药涨1.87% 股价突破300美元大关
市场透视 · 10-24
阿里拉姆制药涨1.87% 股价突破300美元大关
Sensei Biotherapeutics, Inc.盘中异动 急速跳水5.68%报0.531美元
市场透视 · 10-24
Sensei Biotherapeutics, Inc.盘中异动 急速跳水5.68%报0.531美元
Cns Pharmaceuticals, Inc.盘中异动 早盘股价大涨27.38%报0.180美元
市场透视 · 10-24
Cns Pharmaceuticals, Inc.盘中异动 早盘股价大涨27.38%报0.180美元
Cns Pharmaceuticals, Inc.盘中异动 股价大涨115.83%报0.338美元
市场透视 · 10-23
Cns Pharmaceuticals, Inc.盘中异动 股价大涨115.83%报0.338美元
加载更多
公司概况
公司名称:
CNS Pharmaceuticals, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
CNS Pharmaceuticals, Inc.是一家临床前阶段的制药公司,于2017年7月27日组建为内华达州公司,专注于开发用于治疗脑和中枢神经系统肿瘤的抗癌药物,这些药物基于与HPI的许可协议,以及与Reata的合作和资产购买协议。
发行价格:
--
{"stockData":{"symbol":"CNSP","market":"US","secType":"STK","nameCN":"CNS Pharmaceuticals, Inc.","latestPrice":0.13,"timestamp":1732222800000,"preClose":0.1236,"halted":0,"volume":33636163,"hourTrading":{"tag":"盘前","latestPrice":0.125,"preClose":0.13,"latestTime":"05:14 EST","volume":18644,"amount":2302.28454328,"timestamp":1732270485061},"delay":0,"floatShares":56377299,"shares":57486706,"eps":-86.82832,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.0064,"latestTime":"11-22 06:22:15 EST","open":0.132,"high":0.145,"low":0.127,"amount":4504986.50093129,"amplitude":0.145631,"askPrice":0.1411,"askSize":100,"bidPrice":0.125,"bidSize":12402,"shortable":3,"etf":0,"ttmEps":-86.82832,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732285800000},"adr":0,"listingDate":1573189200000,"adjPreClose":0.13,"preHourTrading":{"tag":"盘前","latestPrice":0.125,"preClose":0.13,"latestTime":"05:14 EST","volume":18644,"amount":2302.28454328,"timestamp":1732270485061},"postHourTrading":{"tag":"盘后","latestPrice":0.1276,"preClose":0.13,"latestTime":"19:59 EST","volume":592587,"amount":75689.2193,"timestamp":1732237189456},"volumeRatio":3.848372369329731},"requestUrl":"/m/hq/s/CNSP","defaultTab":"news","newsList":[{"id":"2485979834","title":"Cns Pharmaceuticals, Inc.盘中异动 股价大涨12.70%报0.139美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485979834","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485979834?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:32","pubTimestamp":1732199524,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时32分,Cns Pharmaceuticals, Inc.股票出现异动,股价快速上涨12.70%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.05%。Cns Pharmaceuticals, Inc.公司简介:CNS Pharmaceuticals Inc 是一家临床阶段制药公司,专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122320495be4e8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122320495be4e8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNSP","BK4007"],"gpt_icon":0},{"id":"2485147822","title":"Cns Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.21%报0.133美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485147822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485147822?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:49","pubTimestamp":1732121382,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日00时49分,Cns Pharmaceuticals, Inc.股票出现波动,股价急速拉升5.21%。截至发稿,该股报0.133美元/股,成交量367.106万股,换手率6.39%,振幅9.46%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.70%。Cns Pharmaceuticals, Inc.公司简介:CNS Pharmaceuticals Inc 是一家临床阶段制药公司,专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121004942a2490264&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121004942a2490264&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNSP","BK4007"],"gpt_icon":0},{"id":"2484264689","title":"Cns Pharmaceuticals, Inc.盘中异动 早盘快速下挫5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484264689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484264689?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:08","pubTimestamp":1732028908,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日23时08分,Cns Pharmaceuticals, Inc.股票出现异动,股价急速跳水5.17%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.34%。Cns Pharmaceuticals, Inc.公司简介:CNS Pharmaceuticals Inc 是一家临床阶段制药公司,专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119230828971a7749&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119230828971a7749&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2484676506","title":"Cns Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484676506","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484676506?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:33","pubTimestamp":1731940426,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时33分,Cns Pharmaceuticals, Inc.股票出现波动,股价快速上涨5.52%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.15%。其相关个股中,Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.涨幅较大,Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃,换手率分别为519.51%、222.57%、191.59%,振幅较大的相关个股有Hcw Biologics Inc.、Fate Therapeutics, Inc.、冠科美博,振幅分别为67.89%、41.09%、34.31%。Cns Pharmaceuticals, Inc.公司简介:CNS Pharmaceuticals Inc 是一家临床阶段制药公司,专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822334698e433d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822334698e433d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2483305612","title":"Cns Pharmaceuticals, Inc.盘中异动 大幅下跌5.30%报0.113美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483305612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483305612?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:25","pubTimestamp":1731684321,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时25分,Cns Pharmaceuticals, Inc.股票出现异动,股价大幅下挫5.30%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为3.20%。Cns Pharmaceuticals, Inc.公司简介:CNS Pharmaceuticals Inc 是一家临床阶段制药公司,专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115232521971a6e30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115232521971a6e30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2483043388","title":"Cns Pharmaceuticals, Inc.盘中异动 股价大跌5.46%报0.118美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483043388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483043388?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:44","pubTimestamp":1731595497,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时44分,Cns Pharmaceuticals, Inc.股票出现异动,股价快速下跌5.46%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.44%。Cns Pharmaceuticals, Inc.公司简介:CNS Pharmaceuticals Inc 是一家临床阶段制药公司,专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422445798e42a73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422445798e42a73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ELAB","CNSP","BK4183"],"gpt_icon":0},{"id":"2482736069","title":"CNS Pharmaceuticals Inc 预计每股亏损 10 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482736069","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482736069?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:31","pubTimestamp":1731339119,"startTime":"0","endTime":"0","summary":" * CNS Pharmaceuticals Inc 预计将于 11 月 13 日公布截至 0001 年 1 月 1 日的业绩(预计) * * LSEG分析师对CNS Pharmaceuticals Inc的平均预期是每股亏损10美分。* 分析师对该公司股票的评级为 \"买入\"。* 生物技术与医学研究同行的平均一致建议也是 \"买入\"。* 华尔街对 CNS Pharmaceuticals Inc 的 12 个月目标价中位数为 0.50 美元,高于其 0.12 美元的最新收盘价。11月11日 - 本摘要于北京时间 11 月 11 日 15:31 机器生成。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","CNSP"],"gpt_icon":0},{"id":"2482585738","title":"Cns Pharmaceuticals, Inc.盘中异动 股价大涨5.22%报0.123美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482585738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482585738?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:43","pubTimestamp":1731336181,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时43分,Cns Pharmaceuticals, Inc.股票出现异动,股价急速拉升5.22%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.10%。Cns Pharmaceuticals, Inc.公司简介:CNS Pharmaceuticals Inc 是一家临床阶段制药公司,专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224301971a5b61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224301971a5b61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2481983101","title":"Cns Pharmaceuticals, Inc.盘中异动 急速上涨5.42%报0.117美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481983101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481983101?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:44","pubTimestamp":1730904267,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时44分,Cns Pharmaceuticals, Inc.股票出现异动,股价急速拉升5.42%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.38%。Cns Pharmaceuticals, Inc.公司简介:CNS Pharmaceuticals Inc 是一家临床阶段制药公司,专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106224428971a4caa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106224428971a4caa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNSP","BK4007"],"gpt_icon":0},{"id":"2481685375","title":"Cns Pharmaceuticals, Inc.盘中异动 股价大涨5.51%报0.113美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481685375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481685375?lang=zh_cn&edition=full","pubTime":"2024-11-05 23:05","pubTimestamp":1730819117,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日23时05分,Cns Pharmaceuticals, Inc.股票出现异动,股价快速上涨5.51%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.07%。Cns Pharmaceuticals, Inc.公司简介:CNS Pharmaceuticals Inc 是一家临床阶段制药公司,专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105230518971a4744&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105230518971a4744&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNSP","BK4007"],"gpt_icon":0},{"id":"2480581867","title":"Cns Pharmaceuticals, Inc.股价重挫10.21% 市值跌42.05万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480581867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480581867?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:35","pubTimestamp":1730730902,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时35分,Cns Pharmaceuticals, Inc.股票出现异动,股价大幅跳水10.21%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。Cns Pharmaceuticals, Inc.公司简介:CNS Pharmaceuticals Inc 是一家临床阶段制药公司,专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422350295bdca23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422350295bdca23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNSP","BK4007"],"gpt_icon":0},{"id":"2480881409","title":"Cns Pharmaceuticals, Inc.盘中异动 早盘股价大涨15.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480881409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480881409?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:33","pubTimestamp":1730467981,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时33分,Cns Pharmaceuticals, Inc.股票出现波动,股价大幅上涨15.05%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.31%。其相关个股中,Tc Biopharm Plc C/Wts 10/02/2028 、Klotho Neurosciences Inc C/Wts 21/06/2029 、Theriva Biologics, Inc.涨幅较大,Theriva Biologics, Inc.、Athira Pharma, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为1289.81%、112.23%、75.06%,振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Mesoblast Ltd、Athira Pharma, Inc.,振幅分别为19.38%、18.08%、12.57%。Cns Pharmaceuticals, Inc.公司简介:CNS Pharmaceuticals Inc 是一家临床阶段制药公司,专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121330195bdab30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121330195bdab30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2479603657","title":"Cns Pharmaceuticals, Inc.盘中异动 快速下挫5.35%报0.115美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479603657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479603657?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:14","pubTimestamp":1730384053,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时14分,Cns Pharmaceuticals, Inc.股票出现异动,股价大幅下跌5.35%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为2.90%。Cns Pharmaceuticals, Inc.公司简介:CNS Pharmaceuticals Inc 是一家临床阶段制药公司,专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031221413ab8bc1f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031221413ab8bc1f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNSP","BK4007"],"gpt_icon":0},{"id":"2479784168","title":"Cns Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479784168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479784168?lang=zh_cn&edition=full","pubTime":"2024-10-30 22:32","pubTimestamp":1730298723,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日22时32分,Cns Pharmaceuticals, Inc.股票出现波动,股价大幅跳水5.52%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。其相关个股中,Tharimmune, Inc.、Ensysce Biosciences, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大,Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm Plc较为活跃,换手率分别为3939.71%、1264.62%、72.48%,振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Quince Therapeutics, Inc.,振幅分别为96.06%、70.67%、47.63%。Cns Pharmaceuticals, Inc.公司简介:CNS Pharmaceuticals Inc 是一家临床阶段制药公司,专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103022320398e3f71e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103022320398e3f71e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNSP","BK4007"],"gpt_icon":1},{"id":"2478844054","title":"Cns Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.22%报0.139美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478844054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478844054?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:13","pubTimestamp":1730124838,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时13分,Cns Pharmaceuticals, Inc.股票出现波动,股价大幅拉升5.22%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.52%。Cns Pharmaceuticals, Inc.公司简介:CNS Pharmaceuticals Inc 是一家临床阶段制药公司,专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822135898e3ed74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822135898e3ed74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":1},{"id":"2478933361","title":"Cns Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.22%报0.138美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478933361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478933361?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:32","pubTimestamp":1729863153,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时32分,Cns Pharmaceuticals, Inc.股票出现波动,股价大幅跳水5.22%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.36%。Cns Pharmaceuticals, Inc.公司简介:CNS Pharmaceuticals Inc 是一家临床阶段制药公司,专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521323398e3e7e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521323398e3e7e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNSP","BK4007","ELAB","BK4183"],"gpt_icon":1},{"id":"2477637954","title":"阿里拉姆制药涨1.87% 股价突破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2477637954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477637954?lang=zh_cn&edition=full","pubTime":"2024-10-24 22:01","pubTimestamp":1729778502,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日22时01分,阿里拉姆制药股票出现波动,股价大幅上涨1.87%。截至发稿,该股报300.39美元/股,成交量1.9493万股,换手率0.02%,振幅1.83%。机构评级方面,在所有33家参与评级的机构中,70%的券商给予买入建议,27%的券商给予持有建议,3%的券商给予卖出建议。阿里拉姆制药股票所在的生物技术行业中,整体涨幅为0.63%。阿里拉姆制药公司简介:Alnylam Pharmaceuticals是RNA干扰治疗研究的领导者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422014298e3e428&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422014298e3e428&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348814723.USD","LU1048596156.SGD","BK4579","LU1823568750.SGD","BK4527","BK4538","ALNY","CNSP","LU1515016050.SGD","LU1046421795.USD","BK4139","BK4122","BK4575","LU1051768304.USD","LU0651946864.USD","LU1152091168.USD","LU0797268264.HKD","BK4558","LU1046422090.SGD","BK4524","LU1688375341.USD","LU2226246903.HKD","BK4534","GNPX","BK4220","LU0067412154.USD","BK4548","BK4533","BK4554","LU0918141705.HKD","LU1282648689.USD","BK4526","BK4585","BK4503","LU0918141887.USD","LU1880383366.USD","LU0052756011.USD","BK4588","BK4504","LU0880133367.SGD","IE00B0JY6N72.USD","BK4531","IE00BFMHRM44.USD","BK4587","BK4581","LU1008478684.HKD","LU1105468828.SGD","LU0251143458.SGD","LU1267930227.SGD","LU0348816934.USD"],"gpt_icon":1},{"id":"2477631187","title":"Sensei Biotherapeutics, Inc.盘中异动 急速跳水5.68%报0.531美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477631187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477631187?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:33","pubTimestamp":1729776836,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时33分,Sensei Biotherapeutics, Inc.股票出现异动,股价快速跳水5.68%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.42%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Cns Pharmaceuticals, Inc.、Dbv Technologies涨幅较大,Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Genprex, Inc.较为活跃,换手率分别为199.63%、99.42%、33.61%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Qualigen Therapeutics, Inc.,振幅分别为45.75%、20.04%、13.79%。Sensei Biotherapeutics, Inc.公司简介:Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司,致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024213357ab70a448&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024213357ab70a448&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE","CNSP","GNPX","BK4139"],"gpt_icon":1},{"id":"2477463181","title":"Cns Pharmaceuticals, Inc.盘中异动 早盘股价大涨27.38%报0.180美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477463181","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477463181?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:31","pubTimestamp":1729776685,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时31分,Cns Pharmaceuticals, Inc.股票出现波动,股价急速上涨27.38%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.50%。Cns Pharmaceuticals, Inc.公司简介:CNS Pharmaceuticals Inc 是一家临床阶段制药公司,专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421312695bd4d4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421312695bd4d4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNSP","BK4007"],"gpt_icon":1},{"id":"2477356405","title":"Cns Pharmaceuticals, Inc.盘中异动 股价大涨115.83%报0.338美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477356405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477356405?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:31","pubTimestamp":1729690265,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时31分,Cns Pharmaceuticals, Inc.股票出现波动,股价快速拉升115.83%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。Cns Pharmaceuticals, Inc.公司简介:CNS Pharmaceuticals Inc 是一家临床阶段制药公司,专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321310695bd4286&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321310695bd4286&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cnspharma.com","stockEarnings":[{"period":"1week","weight":0.0934},{"period":"1month","weight":-0.1704},{"period":"3month","weight":-0.3333},{"period":"6month","weight":-0.9876},{"period":"1year","weight":-0.9988},{"period":"ytd","weight":-0.998}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CNS Pharmaceuticals, Inc.是一家临床前阶段的制药公司,于2017年7月27日组建为内华达州公司,专注于开发用于治疗脑和中枢神经系统肿瘤的抗癌药物,这些药物基于与HPI的许可协议,以及与Reata的合作和资产购买协议。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.194164},{"month":2,"riseRate":0.4,"avgChangeRate":-0.000171},{"month":3,"riseRate":0.2,"avgChangeRate":-0.161933},{"month":4,"riseRate":0.4,"avgChangeRate":0.057823},{"month":5,"riseRate":0.4,"avgChangeRate":-0.002034},{"month":6,"riseRate":0.4,"avgChangeRate":-0.170886},{"month":7,"riseRate":0.2,"avgChangeRate":-0.250938},{"month":8,"riseRate":0.4,"avgChangeRate":-0.098088},{"month":9,"riseRate":0,"avgChangeRate":-0.21514},{"month":10,"riseRate":0.2,"avgChangeRate":0.089289},{"month":11,"riseRate":0.6,"avgChangeRate":-0.011077},{"month":12,"riseRate":0,"avgChangeRate":-0.243828}],"exchange":"NASDAQ","name":"CNS Pharmaceuticals, Inc.","nameEN":"CNS Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CNS Pharmaceuticals, Inc.(CNSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CNS Pharmaceuticals, Inc.(CNSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CNS Pharmaceuticals, Inc.,CNSP,CNS Pharmaceuticals, Inc.股票,CNS Pharmaceuticals, Inc.股票老虎,CNS Pharmaceuticals, Inc.股票老虎国际,CNS Pharmaceuticals, Inc.行情,CNS Pharmaceuticals, Inc.股票行情,CNS Pharmaceuticals, Inc.股价,CNS Pharmaceuticals, Inc.股市,CNS Pharmaceuticals, Inc.股票价格,CNS Pharmaceuticals, Inc.股票交易,CNS Pharmaceuticals, Inc.股票购买,CNS Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CNS Pharmaceuticals, Inc.(CNSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CNS Pharmaceuticals, Inc.(CNSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}